Adrenomedullin protects neurons against oxygen glucose deprivation stress in an autocrine and paracrine manner.
The understanding of mechanisms involved in ischaemic brain tolerance may provide new therapeutical targets for stroke. In vivo genomic studies revealed an up-regulation of adrenomedullin expression by hypoxic pre-conditioning. Furthermore, adrenomedullin reduced ischaemia-induced brain damage in rodents. However, whether adrenomedullin is involved in hypoxic pre-conditioning-induced tolerance and whether adrenomedullin protects directly neurons against ischaemia remain unknown. Using a neuronal model of hypoxic pre-conditioning and oxygen glucose deprivation (OGD), we showed that 0.1% or 0.5% of O2 pre-conditioning reduced the OGD-induced neuronal death, whereas 1% or 2% of O2 pre-treatment did not induce neuroprotection. Adrenomedullin expression increased following the hypoxic period, and following OGD only in pre-conditioned (0.1% or 0.5% of O2) neurons. Adrenomedullin pre-treatment and post-treatment reduced the OGD-induced neuronal death, partly through PI3kinase-dependent pathway. However, adrenomedullin antagonism during hypoxic pre-conditioning failed to inhibit the neuroprotection whereas adrenomedullin antagonism following OGD abolished the hypoxic pre-conditioning-induced neuroprotection. Finally, we showed that adrenomedullin is involved in neuroprotection induced by endothelial cells and microglia. In contrast, neuroprotection induced by astrocytes occurred through adrenomedullin-independent mechanisms. Altogether, our results suggest that adrenomedullin is an effector of the hypoxic pre-conditioning-induced neuronal tolerance and a potent autocrine and paracrine neuroprotective factor during cerebral ischaemia.
Tixier
Emmanuelle
E
Centre d'Imagerie-Neurosciences et Applications aux Pathologies (CI-NAPS), UMR 6232, Université de Caen Basse-Normandie, Université Paris Descartes, CNRS, CEA, France.
Leconte
Claire
C
Touzani
Omar
O
Roussel
Simon
S
Petit
Edwige
E
Bernaudin
Myriam
M
D053607:Adrenomedullin / Q000096:biosynthesis / Q000502:physiology*; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D019898:Autocrine Communication / Q000502:physiology*; D015687:Cell Hypoxia / Q000502:physiology; D002478:Cells, Cultured; D005947:Glucose / Q000172:deficiency / Q000502:physiology*; D051379:Mice; D017628:Microglia / Q000378:metabolism; D009474:Neurons / Q000378:metabolism* / Q000502:physiology; D018696:Neuroprotective Agents / Q000378:metabolism*; D018384:Oxidative Stress / Q000502:physiology*; D010100:Oxygen; D019899:Paracrine Communication / Q000502:physiology*; D015854:Up-Regulation / Q000502:physiology
D018696:Neuroprotective Agents; D053607:Adrenomedullin; D005947:Glucose; D010100:Oxygen